NO944920L - Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner - Google Patents
Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinnerInfo
- Publication number
- NO944920L NO944920L NO944920A NO944920A NO944920L NO 944920 L NO944920 L NO 944920L NO 944920 A NO944920 A NO 944920A NO 944920 A NO944920 A NO 944920A NO 944920 L NO944920 L NO 944920L
- Authority
- NO
- Norway
- Prior art keywords
- alopecia
- women
- procedure
- hirsutism
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Det er beskrevet en fremgangsmåte for å Inhibere hirsutisme eller alopecia hos kvinner Innbefattende administrering til en kvinne som har behov for behandling av en effektiv mengde av en forbindelse som har formelen .OCHjCHi¿R2 (I) hvori R1 og R3 uavhengig av hverandre er hydrogen, O -CH3 O -C-(Ci-Cf, alkyl), eller -C-Ar, hvor Ar er eventuelt substituert fenyl; R2 er valgt fra gruppen bestående av pyrrolldlne, heksametylenamino og piperidlno; eller et farmasøytisk akseptabelt salt eller solvat derav.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/171,089 US5574048A (en) | 1993-12-21 | 1993-12-21 | Methods of inhibiting hirsutism and alopecia in women |
Publications (2)
Publication Number | Publication Date |
---|---|
NO944920D0 NO944920D0 (no) | 1994-12-19 |
NO944920L true NO944920L (no) | 1995-06-22 |
Family
ID=22622479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944920A NO944920L (no) | 1993-12-21 | 1994-12-19 | Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner |
Country Status (22)
Country | Link |
---|---|
US (2) | US5574048A (no) |
EP (1) | EP0659414B1 (no) |
JP (1) | JPH07215864A (no) |
KR (1) | KR950016728A (no) |
CN (1) | CN1107703A (no) |
AT (1) | ATE203406T1 (no) |
AU (1) | AU690162B2 (no) |
CA (1) | CA2138498A1 (no) |
CZ (1) | CZ321394A3 (no) |
DE (1) | DE69427807T2 (no) |
DK (1) | DK0659414T3 (no) |
ES (1) | ES2157961T3 (no) |
GR (1) | GR3036977T3 (no) |
HU (1) | HUT71479A (no) |
IL (1) | IL112040A0 (no) |
NO (1) | NO944920L (no) |
NZ (1) | NZ270171A (no) |
PH (1) | PH31440A (no) |
PT (1) | PT659414E (no) |
RU (1) | RU94044457A (no) |
SI (1) | SI0659414T1 (no) |
ZA (1) | ZA9410092B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965551A (en) | 1996-02-21 | 1999-10-12 | North Carolina State University | Method of treating alopecia |
TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
KR20020013533A (ko) | 1999-05-04 | 2002-02-20 | 앤드류 맥린 | 안드로겐 글리코사이드와 그것의 안드로겐 활성 |
US20060263452A1 (en) * | 2005-05-17 | 2006-11-23 | Alwyn Dowell | Topical composition containing essential oils |
WO2011014649A1 (en) | 2009-07-29 | 2011-02-03 | Duke University | Compositions and methods for inhibiting hair growth |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US4859585A (en) * | 1986-04-17 | 1989-08-22 | Trustees Of Tufts College | In-vitro methods for identifying compositions which are agonists and antagonists of estrogens |
US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
-
1993
- 1993-12-19 CZ CZ943213A patent/CZ321394A3/cs unknown
- 1993-12-21 US US08/171,089 patent/US5574048A/en not_active Expired - Fee Related
-
1994
- 1994-12-16 RU RU94044457/14A patent/RU94044457A/ru unknown
- 1994-12-19 IL IL11204094A patent/IL112040A0/xx unknown
- 1994-12-19 SI SI9430389T patent/SI0659414T1/xx unknown
- 1994-12-19 HU HU9403665A patent/HUT71479A/hu unknown
- 1994-12-19 AU AU81550/94A patent/AU690162B2/en not_active Ceased
- 1994-12-19 AT AT94309471T patent/ATE203406T1/de not_active IP Right Cessation
- 1994-12-19 KR KR1019940034919A patent/KR950016728A/ko not_active Application Discontinuation
- 1994-12-19 DK DK94309471T patent/DK0659414T3/da active
- 1994-12-19 CA CA002138498A patent/CA2138498A1/en not_active Abandoned
- 1994-12-19 DE DE69427807T patent/DE69427807T2/de not_active Expired - Fee Related
- 1994-12-19 CN CN94119731A patent/CN1107703A/zh active Pending
- 1994-12-19 PT PT94309471T patent/PT659414E/pt unknown
- 1994-12-19 JP JP6314549A patent/JPH07215864A/ja active Pending
- 1994-12-19 NO NO944920A patent/NO944920L/no unknown
- 1994-12-19 NZ NZ270171A patent/NZ270171A/en unknown
- 1994-12-19 EP EP94309471A patent/EP0659414B1/en not_active Expired - Lifetime
- 1994-12-19 PH PH49587A patent/PH31440A/en unknown
- 1994-12-19 ZA ZA9410092A patent/ZA9410092B/xx unknown
- 1994-12-19 ES ES94309471T patent/ES2157961T3/es not_active Expired - Lifetime
-
1995
- 1995-03-15 US US08/404,858 patent/US5686468A/en not_active Expired - Fee Related
-
2001
- 2001-10-22 GR GR20010401847T patent/GR3036977T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SI0659414T1 (en) | 2001-12-31 |
EP0659414A3 (en) | 1995-09-06 |
CA2138498A1 (en) | 1995-06-22 |
PH31440A (en) | 1998-11-03 |
AU690162B2 (en) | 1998-04-23 |
CN1107703A (zh) | 1995-09-06 |
NO944920D0 (no) | 1994-12-19 |
IL112040A0 (en) | 1995-03-15 |
US5574048A (en) | 1996-11-12 |
GR3036977T3 (en) | 2002-01-31 |
HU9403665D0 (en) | 1995-02-28 |
AU8155094A (en) | 1995-06-29 |
DE69427807T2 (de) | 2001-12-06 |
EP0659414A2 (en) | 1995-06-28 |
DE69427807D1 (de) | 2001-08-30 |
NZ270171A (en) | 1996-08-27 |
DK0659414T3 (da) | 2001-09-24 |
EP0659414B1 (en) | 2001-07-25 |
KR950016728A (ko) | 1995-07-20 |
ATE203406T1 (de) | 2001-08-15 |
JPH07215864A (ja) | 1995-08-15 |
CZ321394A3 (en) | 1995-08-16 |
ZA9410092B (en) | 1996-06-19 |
PT659414E (pt) | 2001-11-30 |
US5686468A (en) | 1997-11-11 |
RU94044457A (ru) | 1996-10-10 |
ES2157961T3 (es) | 2001-09-01 |
HUT71479A (en) | 1995-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9410084B (en) | Methods of inhibiting thrombin | |
GR3036971T3 (en) | Methods for inhibiting endometriosis. | |
NO943878D0 (no) | Hemming av uterinfibrose | |
IL112042A0 (en) | Methods of inhibiting seborrhea and acne | |
IL111289A0 (en) | Methods for inhibiting angiogenesis and angiogenic diseases | |
NO944925D0 (no) | Fremgangsmåte for å öke libido i post-menopausale kvinner | |
NO944929L (no) | Fremgangsmåte for å inhibere CNS-problemer i post-menopausale kvinner | |
NO944920L (no) | Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner |